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of CRC or polyposis syndromes, or any other con traindications to CTC would generally be excluded. All demographic information (age, sex, and race) was obtained from data collected by the techni cian at the time of CTC. Demographics, location, and type of extracolonic finding were entered into the CTC database and secured on a passwordpro tected computer. The protocol was approved by the Walter Reed Army Investigational Review Board (work unit 07-14031EX).
CTC Technique
All patients underwent standard bowel prepa ration, which included either polyethylene glycol (4 L) or a split dose of 45 mL of sodium phos phate the day before the procedure in addition to a single dose of 2% barium sulfate (250 mL) and diatrizoate sodium (60 mL) to tag the stool and colonic fluid, respectively. On the day of the pro cedure, the colon was inflated using an auto mated lowpressure carbon dioxide delivery sys tem (PROTOCO 2 L, EZEM) with CT scout scans obtained before each study to ensure full colonic distention and an adequate field of view.
Examinations were performed using MDCT scanners (8, 16 , or 64MDCT scanner; Light Speed, GE Healthcare). CT scans were performed using a slice thickness of 1.25 mm, equivalent pitch of 1.5, 1 mm reconstruction interval, 100 mAs, 120 kVp, 512 × 512 matrix, and a single 5-20 second breathhold. Both supine and prone acquisitions were obtained for all patients.
The image data were networked to a worksta tion using 3D colon software (V3D Colon, Via tronix). CTCtrained experienced radiologists read each study at the time of the examination, and a CTC report was created. All fourteen ra diologists who routinely read CTC scans during this period had been trained at Walter Reed Army Medical Center to read CTC scans in a weeklong course that required reading scans for 52 patholo gyproven cases of CTC along with an oral exami nation. All CTC scans showing significant lesions were then reviewed by a seasoned CTC radiologist who had read more than 5,000 CTC scans.
CTC Reporting and Data System
In 2005, the Working Group on Virtual Colonoscopy developed a CTC reporting and data system as a way to streamline the classification of both intracolonic and extracolonic findings [12] . The CTC reporting and data system classification provides radiologists with a consistent method to communicate findings, both intracolonic and ex tracolonic, to providers and patients. They also provide clear recommendations regarding radio logic or clinical followup. Standardized reporting can better assist patients and referring physicians in making management decisions on the basis of CTC results [12] .
Intracolonic Findings
The goal of screening CTC is to identify intra colonic premalignant lesions in a noninvasive manner. In our institution, the criteria for a posi tive CTC scan is a polyp 8 mm or larger. Patients with polyps 6-7 mm are recommended to have surveillance CTC at 1 year. Patients with polyps of 8 mm or larger are recommended to undergo a colonoscopy with polypectomy. Polyps are exam 
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ined by the pathologist and surveillance recom mendations are based on the size and histologic analysis of polyps. In this study, we define an in tracolonic highrisk lesion to be an adenoma with highgrade dysplasia or adenocarcinoma. The CTC reporting and data system classi fies these colonic lesions in a systematic way. C0 signifies an inadequate study. C1 describes a nor mal colon, which means no polyps 6 mm or larg er detected. C2 describes intermediate sized pol yps (6-7 mm) fewer than three in number that will require CTC surveillance at 1 year or a colonos copy if chosen. C3 depicts an advanced number of polyps (more than three, 6-9 mm) or larger polyp (≥ 8 mm) that requires a colonoscopy with polypec tomy. C4 simply describes a colonic mass that is likely malignant and requires urgent medical and surgical evaluation. According to this categoriza tion system, patients with C2 lesions will undergo a followup CTC at 1 year, or colonoscopy if desired, whereas patients with C3 and C4 lesions will only be offered colonoscopy for polypectomy.
Extracolonic Findings
Extracolonic findings are not the primary goal of CTC, but radiologists are responsible for evalu ating both intracolonic and extracolonic findings. The focus of the present study was to explore the impact of extracolonic findings on patients under going screening CTC. Any patient with an extra colonic finding, whether significant or insignifi cant, was entered into our database. Our study used a novel categorization system, a CTC report ing and data system [12] , to help classify signifi cant versus insignificant extracolonic lesions.
The CTC reporting and data system divides ex tracolonic findings into four distinct categories (Table 1 ). E1 describes a normal examination or ana tomic variants. E2 describes clinically insignificant findings requiring no further followup, such as sim ple renal or hepatic cysts, uncomplicated gallstones, and kidney stones. E3 describes likely insignificant findings not completely characterized by CTC re quiring a nonurgent workup; examples include small pulmonary nodules and complex renal or ovarian cysts. E4 defines significant findings that are poten tially dangerous and require an expedited workup with at least one other radiology study. Examples of E4 findings are potential malignancies or large abdominal aortic aneurysms [12] (Fig. 1 ). According to this classification, only extracolonic findings as signed to E3 or E4 by the CTC reporting and data system would be recommended for further radiolog ic and medical followup. For our study, a highrisk extracolonic finding would be a lesion that went on to be a malignancy on the basis of pathologic findings or a large abdominal aortic aneurysm (≥ 5 cm) confirmed in the operating room.
Assignment of CTC Reporting and Data System
Because the CTC reporting and data system was not implemented until January 1, 2006, all CTC scans performed between July 2003 and January 1, 2006, were retrieved, and a boardcertified radiolo gist experienced with the CTC reporting and data system reviewed and assigned each CTC report a score based on the CTC reporting and data system. CTC studies performed after January 1, 2006, were routinely given a CTC reporting and data system score (E1, E2, E3, or E4). For patients with multiple extracolonic findings, the CTC reporting and data Veerappan et al.
system score was based on the most significant ex tracolonic finding. For example, a patient with both E4 and E2 findings would be assigned an E4 CTC reporting and data system score.
Follow-Up of CTC Reporting and Data System Findings
The majority of patients enrolled in our health care system received their entire care in military treatment facilities; however, patients were allowed to seek civilian health care if desired. In this co hort, most patients with new E3classified (85.6% [167/195] ) and new E4classified (91.4% [32/35]) extracolonic lesions and all patients with signifi cant intracolonic lesions received followup evalua tions at Walter Reed Army Medical Center or sur rounding military treatment facilities. These results were stored in militarywide computer data systems through which all radiologic, histologic, and clini cal diagnostic studies could be accessed. Prior exist ing extracolonic findings and their evaluations were not repeated and included in this study. All follow up radiologic and surgical procedures were followed over a time interval of 6 months to 4 years (mean fol lowup time, 19.5 ± 10 months). The type, number, and results of these examinations were tabulated, in cluding the final diagnosis, surgeries performed, and cancers identified during the evaluation (Fig. 2) .
Medical Costs
The total and perpatient cost of the followup radiology tests performed to work up patients with significant extracolonic findings (E3 or E4) were calculated using 2007 Medicare reimbursement rates (Table 2) . Perpatient cost was calculated by dividing the total cost of radiology or diagnos tic studies by the number of patients who under went a screening CTC scan (n = 2,277). Radiol ogy costs included all radiology studies generated from the workup of an extracolonic finding. We would include the same study up to a maximum of three times; for example, three CT scans of the chest were included in the evaluation of a pulmo nary nodule. Surgical procedures were not includ ed in the rudimentary cost analysis. Total cost was based on an 86.5% followup rate. We extrapolat ed the total cost calculations to estimate the total cost and perpatient cost for a 100% followup.
Statistical Analysis
Continuous data are expressed as mean ± SD. Categorical data are expressed as ratios and per centages. Differences in patient age between the three CTC reporting and data system scores (E2, E3, and E4) were compared using oneway analysis of variance. Sex and race differences between CTC reporting and data system scores were analyzed with Fisher's exact test. Fisher's exact test was used to compare the proportion of patients with signifi cant lesions or malignancies or who underwent sur gery between the CTC reporting and data system groups. McNemar's test was used to compare the number of significant colonic findings versus the total number of overall findings (colonic plus extra colonic). A probability of 0.05 or less was consid ered to be statistically significant.
Results
Of 2,277 patients undergoing screening CTC (mean age, 59 ± 11 years; 60% white; 56% male), extracolonic findings were identi fied in 1,037 (46%) patients, with 787 (34.6%) insignificant and 240 (11.0%) significant find ings; 54.5% (1,240) of the 2,277 patients had no extracolonic findings (E1), whereas 46% (1,037) had at least one extracolonic finding. Patients with extracolonic findings were clas sified as follows: E2, 787 patients (34.6%); E3, 211 patients (9.3%); and E4, 39 patients (1.7%) (Fig. 3) . Demographic characteristics of patients with extracolonic findings included a mean age of 61.4 ± 11 years old, 53% male, and 61% white. There were no significant de mographic differences in the mean age, sex, or race of patients among the different CTC reporting and data system scores ( Table 3) .
The findings for patients in the E2 group (n = 787) were considered clinically unim portant, 80% of which were renal cysts, neph rolithiasis, hiatal hernias, or benign liver cysts. The majority of findings for patients in the E3 group (n = 211) were pulmonary nodules larg er than 5 mm and complex renal and ovari an cysts. New findings were noted in 92.4% (195/211) of patients in the E3 group; 85.6% (167/195) of those patients were followed up in the military health care system (Table 4) . E4 lesions were noted in 1.7% (n = 39) of the entire population. Of these findings, 89.7% (35/39) were new findings, and 91.4% (32/35) of these patients were followed up in the mil itary health care system. The most common E4 finding was a kidney mass, which made up 41% (16/39) of E4 findings (Table 5) .
According to the CTC reporting and data system recommendations, patients in the E2 group required no further workup and there fore were not assessed in this study. Patients with followup for E3 findings (n = 167) gen erated 158 CT scans, 47 ultrasound scans, five PET scans, nine MRI scans, and 14 other studies. These studies generated a total radiol ogy cost of $87,911. The evaluation of the 32 patients with followup for E4 findings gen erated 24 CT scans, 10 ultrasound scans, five PET scans, four MRI scans, one echocardio gram, one upper endoscopy, one endoscopic Veerappan et al. ultrasound, one bronchoscopy, and one abdominal radio graph. These radiology and endoscopic studies generated a total radiology cost of $25,268 (Table 6 ). The total cost of evaluating E3 ($87,911) and E4 ($25,268) lesions with radiology and endoscopy studies was calculated to be $113,179, based on an 86.5% follow up rate. This resulted in a perpatient cost of $50 ($113 [179/2,277]). We extrapolated this cost for a 100% fol lowup rate to be $130,842, or $57 per patient, for a com plete radiology and endoscopic evaluation of an abnor mal extracolonic finding on CTC.
Extracolonic Findings With CT Colonography
There were a total of 19 surgeries performed to work up the patients in the E3 and E4 groups. Patients in the E4 group were significantly more likely to require diag nostic surgery to work up extracolonic findings than were patients in the E3 group (37.5% [12/32] vs 4.2% [7/167] ; p < 0.0001). Of the 19 patients undergoing sur gery, six extracolonic malignancies were identified. Inter estingly, none of the eight patients (two in the E3 group and six in the E4 group) who underwent surgery for pelvic masses ultimately had a malignancy. Overall, only 0.83% (19/2,277) patients undergoing screening CTC required surgical evaluation as part of the workup.
A greater number of highrisk lesions (malignancy or dangerous aortic aneurysm) were identified in the pa tients who followed up their E4 findings (18.8% [6/32]) compared with E3 findings (0.6% [1/167]) patients (p < 0.0001). These data, along with surgery data, confirm the use of the CTC reporting and data system as an effective classification for organizing and triaging the workup of extracolonic findings. One patient in the E3 group had a stage IA adenocarcinoma of the lung and underwent cura tive resection. Six patients in the E4 group had five malig nancies and one dangerous aortic aneurysm. The five ma lignancies included three renal cell carcinomas (two stage I and one stage II) cured by total nephrectomy, one re current bronchoalveolar carcinoma of the left lung (stage IV), and one nodular lymphoma (stage IIIb). The latter two patients underwent chemotherapy. One patient in the E4 group had an 8 cm abdominal aortic aneurysm that was repaired successfully. Four (66%) of six extracolonic can cers identified on CTC were cured with resection.
In this study population (n = 2,277), 8.52% (194/2,277) of patients were found to have a positive CTC (C3 or C4) that would require a followup colonoscopy for polypec tomy. Highrisk intracolonic findings included six co lorectal adenocarcinomas and three adenomas with high grade dysplasia. Of the nine patients, curative resection was accomplished in six patients (66%), whereas three of the CRCs had either lymph node involvement or distant metastasis. The size of these nine adenocarcinomas and highgrade dysplasia lesions ranged from 15 to 64 mm.
We examined the increase in diagnostic yield that results from considering both intracolonic and extracolonic high risk findings identified on CTC. In this study, when we con sidered extracolonic findings, a total of 16 highrisk lesions (nine intracolonic and seven extracolonic) were identified, increasing the diagnostic yield by 78% (9-16; p = 0.0156) (Fig. 4) . Of these patients, 69% (11/16) underwent curative resection (three colon cancers, three highgrade dysplasia colon lesions, three renal cell cancers, one pulmonary ad
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enocarcinoma, and one aortic aneurysm), and 44.5% (5/11) of those patients had extracolonic findings on CTC.
Discussion
CRC screening is an accepted part of medi cal practice, with optical colonoscopy being performed every 10 years beginning at age 50 years. CTC has shown sensitivity and specific ity similar to that of optical colonoscopy, as confirmed in a recent multicenter trial [13] , with the added advantage of identifying extra colonic lesions. This study shows that signifi cant extracolonic lesions identified during CTC increased the overall diagnostic yield of this examination. Specifically, clinically significant findings requiring urgent medical or surgical management increased by 78% (16 vs nine), re sulting in the discovery of six more cancers and a large aortic aneurysm. Interestingly, CTC used for CRC screening identified almost as many extracolonic cancers as intracolonic can cers. There were a total of six extracolonic can cers (one lymphoma, three renal cell cancers, and two lung cancers) identified in this popula tion, in addition to six colon cancers and three adenomas with highgrade dysplasia. Impor tantly, 66.7% (4/6) of these extracolonic malig nancies underwent curative resection, com pared with 50% (3/6) of colon cancers identified. Of 2,277 patients undergoing CTC for CRC screening, extracolonic findings dou bled the yield of cancer identification from six to 12. This is a clear advantage of this new technology that needs to be weighed into future recommendations concerning CRC screening. Additionally, individuals interpreting CTC scans must be well trained in identifying both intracolonic and extracolonic lesions.
The negative aspects of extracolonic find ings include the added diagnostic cost and physician time to evaluate these findings. Ad ditionally, extracolonic findings may poten tially subject patients to the increased anxi ety and risks (e.g., biopsies and exploratory surgeries) associated with working up insig nificant findings. The CTC reporting and data system was developed to accurately catego rize extracolonic findings as significant or in significant and to systematically identify le sions that required further evaluation. With the institution of the CTC reporting and data system, the actual number of patients requir ing further evaluation decreased to primari ly those with E3 and E4 findings (250 [11%] of 2,277 patients). The major benefit to this classification system is to provide the order ing physician confidence in avoiding unneces sary workup and cost of benign findings (i.e., those classified as E2). Hence, CRC screening with CTC and use of the CTC reporting and data system may have the added advantage of discovering curable extracolonic cancers for minimal additional cost.
In the current study, 89% of patients either did not have extracolonic findings (54%) or had insignificant E2 findings (35%) and re quired no further evaluation. The 11% of pa tients with significant extracolonic findings requiring followup in our study is similar to the 8-10% suggested by studies with asymp tomatic screening populations [7, 8, 14, 15] . Of the 11% of patients with significant extra colonic findings, further evaluation was jus tified, because seven patients were identified with a highrisk lesion (malignancy or dan gerous aortic aneurysm). The fact that almost all the highrisk lesions (6/7) were noted in patients with E4 findings shows the relative accuracy of the CTC reporting and data sys tem when interpreted by radiologists trained and familiar with this categorizing system.
The radiology examinations used to eval uate these extracolonic findings increased the estimated cost of CRC screening with CTC by $57 per patient. This straightfor ward costeffectiveness assessment examin ing shortterm radiology costs has been du plicated in other studies with similar results [5, 8, 14, 16] . A more extensive costeffec tiveness analysis would include identifying every aspect of medical and clerical costs, which has been attempted by Gluecker et al. [8] . Including the additional costs of the surgeries, clinical visits, and other adminis trative costs would have added to the over all cost of working up extracolonic findings. Other studies dealing with screening popula tions have quoted slightly lower costs ($24-34) to work up these findings [5, 8, [14] [15] [16] .
The difference in cost may be the result of increased Medicare reimbursement rates and our ability to capture the majority of radiol ogy and procedural studies with our unified military medical databases. Another poten tial reason for increased workup costs could be related to variations in workup patterns at different institutions. Our institution may un dergo a more extensive workup for a lesion that may be evaluated with a single study elsewhere. Another recent costeffectiveness analysis created a Markov model to show that the addition of finding significant extra colonic findings during CTC made it more cost effective than colonoscopy [17] .
There are limitations inherent to any ret rospective study. For example, 100% follow up is difficult to achieve in a retrospective cohort because it is not possible to control for patients' followup patterns. However, the military health care system is unique in that the electronic medical record spans the en tire military worldwide, which means that we can follow up patients who have left our immediate area; such patients can be fol lowed up anywhere in the military, which is the reason for our reasonably good followup rates (86.5%). It is possible that some pa tients are followed up in civilian care, and that is why we do not have their results in cluded in our study. Other reasons that are important to mention are noncompliance or a decision by a provider not to pursue a work up, which may actually mean that our extrap olation to 100% followup rate may overesti mate costs. This fact leads us to think that the additional cost would likely be some where between $50-57 per patient.
The retrospective design of this study allows us to understand the natural history of the out comes of these extracolonic findings. The abil ity to follow these patients over time and note the natural radiology ordering patterns of pri mary care physicians is a realistic understand ing of costs and studies generated. In addition, following patients out to their final diagnosis and, especially, establishing histologic diagno ses for these malignancies give us a better idea of the true rates of these malignancies. A recent metaanalysis by Xiong et al. [7] summarized in their populations compared with the lower rate of 0.26% in our study [7] . There are mul tiple reasons for this high rate, including the heterogeneous populations studied and the fact the malignancy rates included "presumed ma lignancies." Most of these studies did not in clude biopsyproven malignancy, which gross ly overestimates the actual number of cancers. In our study, only five (16%) of 31 patients who were followed up for E4 findings suggestive of malignancy had a biopsyproven malignancy. This finding suggests that a much smaller per centage of patients than is suspected after CTC will go on to have a true malignancy. An important question regarding the cost of procedure is the potential morbidity of this ex tensive workup, which may require surgery to rule out these findings. In our population of 2,277 patients, 19 surgeries were performed to identify six malignant lesions and a highrisk aortic aneurysm. Interestingly, in patients with pelvic masses, none of the surgeries (0/8) proved to be a malignant ovarian mass, which was similar to findings (0/10) in a study by Pickhardt et al. [15] of a similar population of asymptomatic patients. In the bigger picture, only 0.8% (19/2,277) of patients required a di agnostic surgery, with 31.5% of these patients (6/19) with histologically proven malignancy, which seems to be an acceptable risk for a sub stantial gain. The overall morbidity and finan cial impact of extracolonic findings on a screen ing population seems minimal for relatively high reward.
Another strength of our study is the CTC technique and protocol used. CTC was per formed using the technique previously de scribed by Pickhardt et al. [3] , which achieved sensitivities and specificities (> 90%) similar to those of optical colonoscopy in identifying co lonic lesions larger than 8 mm. In our study, followup optical colonoscopy was recom mended for 8.52% (194/2,277) of patients, which is similar to a referral rate of 7.9% in a screening population in a recent study by Kim et al. [4] that used similar colonic preparations and computer software. These similar follow up rates attest to the consistency of CTC when using similar methodologies and interpretation by welltrained radiologists.
Between 1998 and 2008, there were 20 studies with populations of 40-3,120 patients that described CTC extracolonic findings in patients that were symptomatic or asympto matic or both [3, 4, 6-8, 10, 11, 14-16, 18-27] . Of these 20 studies, seven enrolled more than 500 patients and five enrolled more than 1,000 patients; one study was a systematic re view [3, 4, 7, 8, 14, 15, 18] . Studies that includ ed symptomatic patients tended to identify more extracolonic cancers. Of the four studies (n > 1,000) of asymptomatic screening popu lations reporting data on both intracolonic and extracolonic cancers, there were a total of 25 (0.38%) extracolonic cancers and 22 (0.33%) CRCs among 6,583 patients [3, 4, 18] . When taking extracolonic malignancies into account, the diagnostic yield for identifying malignan cies on screening CTC in these three large studies increased by 113%, from 22 to 47. In our study, we identified a similar rate of extra colonic malignancies (0.26% [6/2,277]) and intracolonic malignancies (0.26% [6/2,277]), which also doubles the yield (from six to 12) of identifying any malignancy.
It is important to understand that CTC is by no means a replacement for a CT of the abdomen and pelvis for detecting significant extracolonic lesions. Because of the lack of IV contrast material and the low dose of ra diation, the sensitivity of CTC for identify ing extracolonic lesions is much lower than that for a regular CT scan [9, 19] . This mes sage needs to be communicated to referring physicians and patients undergoing CTC for screening. Although CTC can identify le sions outside of the colon, these findings of ten have to be further characterized, and this test should not be relied on as a tool to rule out disease in the abdomen or pelvis.
In conclusion, although the medical com munity has already accepted that CRC screen ing is cost effective and saves lives, CTC not only identifies CRC but also doubles the yield of identifying significant early extracolon ic lesions, resulting in lives saved. These re sults represent a compelling reason to con sider CTC either as an alternative to optical colonoscopy CRC screening or as a onetime procedure to identify significant treatable in tracolonic and extracolonic lesions.
